This Small Biotech Rival To J&J Just Rocketed 44% – Investor's Business Daily

Business News

  1. This Small Biotech Rival To J&J Just Rocketed 44%  Investor’s Business Daily
  2. CG Oncology’s Bladder Cancer Drug Impresses Investors – Here’s Why  Yahoo Finance
  3. Dr Dinney on the Association Between UGDB and Cretostimogene Grenadenorepvec Response in NMIBC  OncLive
  4. Cretostimogene yields high CR rate in BCG-unresponsive NMIBC  Urology Times
  5. CG Oncology Announces Best-In-Disease Durability Data In Bond-003 Cohort C & Promising Early Signal In Cohort P For Cretostimogene Grenadenorepvec  TradingView

Source: Business News

/by